Recovery act tissue samples and data from various cancer types for the cancer genome atlas (TCGA) program arra::yes::arra
Ended Awarded Last action
- Contract number
- HHSN26100001
- Awardee
-
Brigham & Womens Hospital Inc. UEI QN6MS4VN7BD1 Part of Partners Healthcare System Incorporated
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $63,000
Award facts
- Contract value 100% obligated
- $63,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Boston, MA 02115, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$150,900 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $20,700 | |
| Funding Only Action | $124,200 | |
| Original award | $69,000 |
About this award
This is a firm fixed price delivery order contract awarded by the National Cancer Institute (NCI), a component of the Department of Health and Human Services, to Brigham & Women's Hospital Inc. for the Cancer Genome Atlas (TCGA) program. The $63,000 award supports the collection of tissue samples and data from various cancer types for the TCGA program, which is funded under the American Recovery and Reinvestment Act (ARRA). Brigham & Women's Hospital is a major academic medical center and research institution based in Boston, Massachusetts. The award is not designated as a small business set-aside. The contract is a delivery order under the NCI Cancer Genome Atlas Program Tissue Purchase indefinite delivery contract, which has a total ceiling value of $1,480,427 and runs through May 2029. This contract vehicle allows the NCI to efficiently procure specialized genomic research services from Brigham & Women's Hospital to support its precision medicine initiatives for cancer research.
Quick answers
Who was awarded contract HHSN26100001?
HHSN26100001 was awarded to Brigham & Womens Hospital Inc. by National Cancer Institute (National Institutes of Health) on May 5, 2010.
How much is contract HHSN26100001 worth?
The government has obligated $63,000 on HHSN26100001.
Is contract HHSN26100001 an order under another contract?
Yes. HHSN26100001 is a delivery order under HHSN261201000034I, an indefinite delivery contract, on NCI Cancer Genome Atlas Program Tissue Purchase.
Was contract HHSN26100001 competed?
The extent of competition for HHSN26100001 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award